SINTX Technologies Announces Appointment of Eric K. Olson as Chief Executive Officer
August 06, 2024 09:00 ET
|
SINTX Technologies, Inc.
Salt Lake City, Utah., Aug. 06, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) today announced that its Board of Directors has appointed Eric K. Olson to...
[Latest] Global Medical Aesthetics Market Size/Share Worth USD 36,168.8 Million by 2033 at a 8.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
August 06, 2024 03:30 ET
|
Custom Market Insights
Austin, TX, USA, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Medical Aesthetics Market Size, Trends and Insights By Product Type (Aesthetic...
LogicMark, Inc. Announces Closing of $4.5 Million Public Offering Priced At-The-Market
August 05, 2024 16:05 ET
|
LogicMark, Inc.
LOUISVILLE, Ky., Aug. 05, 2024 (GLOBE NEWSWIRE) -- LogicMark, Inc. (Nasdaq: LGMK), a provider of personal emergency response systems, health communications devices, and technology for the growing...
Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update
August 01, 2024 16:05 ET
|
Lumos Pharma, Inc.
Following Positive End of Phase 2 Meeting with FDA, Company Continues to Advance Plans for Phase 3 Placebo-Controlled Trial of LUM-201 in Moderate Pediatric Growth Hormone Deficiency Expects to...
Retrieve Medical, Inc. and OnPoint Healthcare Partners, Inc., Announce Revolutionary Integration Partnership
August 01, 2024 13:35 ET
|
Retrieve Medical, Inc.
BEDMINSTER, N.J., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Retrieve Medical, Inc. (retrievemedical.com) today announced a technology partnership with OnPoint Healthcare Partners, Inc....
Intelligent Bio Solutions Partners with CenExel to Conduct Clinical Study as Part of FDA 510(k) Pathway
August 01, 2024 08:30 ET
|
Intelligent Bio Solutions, Inc.
Intelligent Bio Solutions Inc. (INBS) partners with CenExel to perform a method comparison clinical study as part of the Company’s FDA clinical study plan.
ViaDerma Finalizes Distribution Agreements in Dubai and Announces Six New Key Hires
August 01, 2024 08:00 ET
|
ViaDerma, Inc.
ViaDerma announces strategic new agreements to move forward its global expansion.
Lumos Pharma to Report Second Quarter 2024 Financial Results and Provide Clinical Update on August 1, 2024
July 23, 2024 16:05 ET
|
Lumos Pharma, Inc.
AUSTIN, Texas, July 23, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a late-stage biopharmaceutical company focused on therapeutics for rare diseases, announced it will report second...
Global Medical Imaging Equipment Market is Expected to Reach USD 74,216.80 Million by 2032, With a CAGR of 5.3% From 2024 to 2032- Report by Polaris Market Research (PMR)
July 16, 2024 09:00 ET
|
Polaris Market Research & Consulting LLP
New York, USA, July 16, 2024 (GLOBE NEWSWIRE) -- Market Overview: The Medical Imaging Equipment Market was estimated at USD 46,639.36 million in 2023. The market valuation is expected to be USD...
Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inhibitors at International Herpesvirus Workshop
July 15, 2024 08:00 ET
|
Assembly Biosciences, Inc.
– Data from both ABI-5366 and ABI-1179, novel long-acting helicase-primase inhibitor candidates for recurrent genital herpes, to be presented – – Poster presentation highlights key preclinical data...